[{"NetIncomeLoss_1_Q1_USD":17371000.0,"Liabilities_0_Q1_USD":1643043000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":5817000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":18275000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":279597000.0,"DerivativeLiabilitiesCurrent_0_Q1_USD":8642000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":60000000.0,"InterestPaidNet_1_Q1_USD":1465000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":5004000.0,"IncomeTaxesPaid_1_Q1_USD":2998000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-70788000.0,"Depreciation_1_Q1_USD":22585000.0,"AccruedIncomeTaxes_0_Q1_USD":7212000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5010619000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":205000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":399225000.0,"ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_1_Q1_USD":-2752000.0,"AssetsCurrent_0_Q1_USD":2288766000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q1_USD":165001000.0,"OtherNoncashIncomeExpense_1_Q1_USD":871000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":237171000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":174318000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":18773000.0,"GainLossOnSaleOfOtherAssets_1_Q1_USD":0.0,"SalesAndExciseTaxPayableCurrent_0_Q1_USD":1406000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":1076127000.0,"CommonStockSharesIssued_0_Q1_shares":182670614.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":0.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":355760000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":194637000.0,"OtherAssetsNoncurrent_0_Q1_USD":141198000.0,"ConvertibleDebt_0_Q1_USD":1076127000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":858000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-1617000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":148725000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":242325000.0,"EarningsPerShareBasic_1_Q1_USD":0.1,"CommonStockIssuedEmployeeStockTrust_0_Q1_USD":9558000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":184365000.0,"AccountsReceivableNetCurrent_0_Q1_USD":396097000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5857000.0,"CommonStockValue_0_Q1_USD":183000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-205000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":667313000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":321127000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":-42784000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":27983000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q1_USD":-443000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-3950000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-24364000.0,"DerivativeFairValueOfDerivativeLiability_0_Q1_USD":12013000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":2255000.0,"CostsAndExpenses_1_Q1_USD":460944000.0,"OtherAssetsCurrent_0_Q1_USD":91249000.0,"IncreaseDecreaseInInventories_1_Q1_USD":6425000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":17371000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":38514000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-72304000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":1408618000.0,"Assets_0_Q1_USD":5805053000.0,"ShareBasedCompensation_1_Q1_USD":49503000.0,"CommonStockSharesOutstanding_0_Q1_shares":182670614.0,"EarningsPerShareDiluted_1_Q1_USD":0.09,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-1351000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":657296000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":21143000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":3319000.0,"Goodwill_0_Q1_USD":196199000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":23228000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":29097000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":113512000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":78572000.0,"GainLossOnDispositionOfAssets1_1_Q1_USD":0.0,"OciBeforeReclassificationsBeforeTaxAttributableToParent_1_Q1_USD":17948000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":181772000.0,"CostOfRevenue_1_Q1_USD":120166000.0,"LiabilitiesCurrent_0_Q1_USD":430035000.0,"InterestExpense_1_Q1_USD":3804000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":667313000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":405903000.0,"DerivativeFairValueOfDerivativeAsset_0_Q1_USD":15270000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":17371000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":2747000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":29153000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-1084000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1022474000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":30810000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-40294000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":18155000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_1_Q1_USD":1800000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":4400000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q1_USD":3746000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1429386000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":1098133000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":486030000.0,"OperatingIncomeLoss_1_Q1_USD":25086000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":420178000.0,"InventoryNet_0_Q1_USD":713929000.0,"InvestmentIncomeInterest_1_Q1_USD":2439000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":11227000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":648228000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":3335000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":5805053000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":117934000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":49503000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1679770000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":107728000.0,"StockholdersEquity_0_Q1_USD":4162010000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":25507000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":1100000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1405504000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-673000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":2304000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":1043000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-844238000.0,"InterestOnConvertibleDebtNetOfTax_1_Q1_USD":0.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":122900000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210430"}]